Principal Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $193M | Sell |
389,511
-37,012
| -9% | -$16.4M | 0.1% | 196 |
|
|
2026
Q1 | $190M | Buy |
426,523
+11,423
| +3% | +$5.33M | 0.1% | 187 |
|
|
2025
Q4 | $188M | Buy |
415,100
+8,600
| +2% | +$3.71M | 0.1% | 194 |
|
|
2025
Q3 | $159M | Sell |
406,500
-3,305
| -0.8% | -$1.38M | 0.08% | 210 |
|
|
2025
Q2 | $182M | Sell |
409,805
-4,566
| -1% | -$2.1M | 0.1% | 194 |
|
|
2025
Q1 | $201M | Buy |
414,371
+17,839
| +4% | +$8.31M | 0.11% | 170 |
|
|
2024
Q4 | $160M | Sell |
396,532
-13,827
| -3% | -$6.41M | 0.09% | 201 |
|
|
2024
Q3 | $191M | Buy |
410,359
+21,649
| +6% | +$10.4M | 0.1% | 175 |
|
|
2024
Q2 | $182M | Buy |
388,710
+25,573
| +7% | +$11.1M | 0.11% | 166 |
|
|
2024
Q1 | $152M | Sell |
363,137
-5,591
| -2% | -$2.36M | 0.09% | 195 |
|
|
2023
Q4 | $150M | Buy |
368,728
+40,005
| +12% | +$14.8M | 0.1% | 187 |
|
|
2023
Q3 | $114M | Sell |
328,723
-2,220
| -0.7% | -$776K | 0.08% | 208 |
|
|
2023
Q2 | $116M | Sell |
330,943
-2,644
| -0.8% | -$891K | 0.08% | 223 |
|
|
2023
Q1 | $105M | Buy |
333,587
+2,463
| +0.7% | +$739K | 0.08% | 230 |
|
|
2022
Q4 | $95.6M | Sell |
331,124
-25,034
| -7% | -$7.63M | 0.07% | 247 |
|
|
2022
Q3 | $103M | Buy |
356,158
+39,731
| +13% | +$11.4M | 0.08% | 216 |
|
|
2022
Q2 | $89.2M | Buy |
316,427
+15,590
| +5% | +$4.17M | 0.07% | 249 |
|
|
2022
Q1 | $78.5M | Sell |
300,837
-5,475
| -2% | -$1.3M | 0.05% | 311 |
|
|
2021
Q4 | $67.3M | Sell |
306,312
-13,734
| -4% | -$2.67M | 0.04% | 358 |
|
|
2021
Q3 | $58.1M | Buy |
320,046
+4,658
| +1% | +$909K | 0.04% | 387 |
|
|
2021
Q2 | $63.6M | Sell |
315,388
-11,611
| -4% | -$2.43M | 0.04% | 368 |
|
|
2021
Q1 | $70.3M | Sell |
326,999
-21,630
| -6% | -$4.75M | 0.05% | 322 |
|
|
2020
Q4 | $82.4M | Sell |
348,629
-18,731
| -5% | -$4.3M | 0.06% | 284 |
|
|
2020
Q3 | $100M | Sell |
367,360
-24,321
| -6% | -$6.71M | 0.08% | 231 |
|
|
2020
Q2 | $114M | Buy |
391,681
+23,036
| +6% | +$6.25M | 0.1% | 212 |
|
|
2020
Q1 | $87.7M | Buy |
368,645
+671
| +0.2% | +$154K | 0.1% | 224 |
|
|
2019
Q4 | $80.6M | Sell |
367,974
-9,263
| -2% | -$1.87M | 0.07% | 305 |
|
|
2019
Q3 | $63.9M | Sell |
377,237
-1,999
| -0.5% | -$354K | 0.06% | 334 |
|
|
2019
Q2 | $69.5M | Buy |
379,236
+1,625
| +0.4% | +$284K | 0.06% | 313 |
|
|
2019
Q1 | $69.5M | Sell |
377,611
-1,287
| -0.3% | -$238K | 0.06% | 309 |
|
|
2018
Q4 | $62.8M | Sell |
378,898
-5,530
| -1% | -$958K | 0.07% | 308 |
|
|
2018
Q3 | $74.1M | Buy |
384,428
+7,957
| +2% | +$1.42M | 0.07% | 310 |
|
|
2018
Q2 | $64M | Sell |
376,471
-461
| -0.1% | -$71.5K | 0.06% | 341 |
|
|
2018
Q1 | $61.4M | Sell |
376,932
-322
| -0.1% | -$52.6K | 0.06% | 356 |
|
|
2017
Q4 | $56.5M | Buy |
377,254
+5,450
| +1% | +$807K | 0.05% | 392 |
|
|
2017
Q3 | $56.5M | Sell |
371,804
-8,034
| -2% | -$1.21M | 0.05% | 387 |
|
|
2017
Q2 | $49M | Buy |
379,838
+10,471
| +3% | +$1.26M | 0.05% | 417 |
|
|
2017
Q1 | $40.4M | Buy |
369,367
+5,907
| +2% | +$520K | 0.05% | 401 |
|
|
2016
Q4 | $26.8M | Sell |
363,460
-1,276
| -0.3% | -$104K | 0.03% | 547 |
|
|
2016
Q3 | $31.8M | Buy |
364,736
+10,094
| +3% | +$954K | 0.04% | 447 |
|
|
2016
Q2 | $30.5M | Buy |
354,642
+9,019
| +3% | +$779K | 0.04% | 426 |
|
|
2016
Q1 | $27.5M | Buy |
345,623
+8,413
| +2% | +$761K | 0.04% | 442 |
|
|
2015
Q4 | $42.4M | Buy |
337,210
+7,517
| +2% | +$907K | 0.06% | 292 |
|
|
2015
Q3 | $34.3M | Buy |
329,693
+6,569
| +2% | +$844K | 0.05% | 340 |
|
|
2015
Q2 | $39.9M | Sell |
323,124
-11,541
| -3% | -$1.45M | 0.06% | 321 |
|
|
2015
Q1 | $39.5M | Buy |
334,665
+9,803
| +3% | +$1.17M | 0.06% | 322 |
|
|
2014
Q4 | $38.6M | Buy |
324,862
+11,445
| +4% | +$1.29M | 0.06% | 317 |
|
|
2014
Q3 | $35.2M | Buy |
313,417
+8,469
| +3% | +$806K | 0.06% | 326 |
|
|
2014
Q2 | $28.9M | Buy |
304,948
+3,044
| +1% | +$213K | 0.05% | 379 |
|
|
2014
Q1 | $21.4M | Buy |
301,904
+3,822
| +1% | +$303K | 0.04% | 475 |
|
|
2013
Q4 | $22.1M | Buy |
298,082
+2,820
| +1% | +$196K | 0.04% | 452 |
|
|
2013
Q3 | $22.4M | Sell |
295,262
-245,187
| -45% | -$19.5M | 0.05% | 411 |
|
|
2013
Q2 | $43.2M | Buy |
+540,449
| New | +$39.8M | 0.1% | 258 |
|
Other funds holding VRTX
Principal Financial Group's VRTX Position: Q2 2026 in Review
Principal Financial Group reduced its Vertex Pharmaceuticals (VRTX) stake by 8.7% in Q2 2026, selling an estimated $16.4M and leaving 389,511 shares worth $193M. The position accounts for 0.1% of the portfolio, ranked #196.
Principal Financial Group first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $201M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Principal Financial Group held 389,511 shares of Vertex Pharmaceuticals worth $193M as of Q2 2026.
- Principal Financial Group sold 37,012 Vertex Pharmaceuticals shares in Q2 2026, an estimated $16.4M.
- Vertex Pharmaceuticals made up 0.1% of Principal Financial Group's portfolio in Q2 2026, its #196 holding.
- Principal Financial Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Principal Financial Group's Vertex Pharmaceuticals position peaked at $201M in Q1 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.